Massachusetts Financial Services Co. MA lessened its position in Molina Healthcare (NYSE:MOH) by 56.6% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 190,063 shares of the company’s stock after selling 247,884 shares during the period. Massachusetts Financial Services Co. MA’s holdings in Molina Healthcare were worth $15,429,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of MOH. Amundi Pioneer Asset Management Inc. bought a new stake in shares of Molina Healthcare in the 4th quarter worth $100,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Molina Healthcare by 40.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,404 shares of the company’s stock worth $184,000 after buying an additional 690 shares in the last quarter. Connable Office Inc. bought a new stake in shares of Molina Healthcare in the 4th quarter worth $203,000. Xact Kapitalforvaltning AB bought a new stake in shares of Molina Healthcare in the 4th quarter worth $310,000. Finally, PEAK6 Investments L.P. raised its stake in shares of Molina Healthcare by 187.1% in the 4th quarter. PEAK6 Investments L.P. now owns 4,140 shares of the company’s stock worth $317,000 after buying an additional 2,698 shares in the last quarter.
Get Molina Healthcare alerts:In other news, Director John C. Molina sold 62,420 shares of Molina Healthcare stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $72.13, for a total transaction of $4,502,354.60. Following the transaction, the director now owns 393,410 shares in the company, valued at $28,376,663.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director John C. Molina sold 20,741 shares of Molina Healthcare stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $72.36, for a total value of $1,500,818.76. Following the transaction, the director now owns 393,410 shares in the company, valued at approximately $28,467,147.60. The disclosure for this sale can be found here. Insiders have sold 87,061 shares of company stock worth $6,305,956 in the last quarter. 0.65% of the stock is currently owned by corporate insiders.
Shares of NYSE MOH opened at $87.60 on Friday. The company has a debt-to-equity ratio of 0.98, a quick ratio of 1.36 and a current ratio of 1.36. The firm has a market capitalization of $5.40 billion, a P/E ratio of 27.63, a P/E/G ratio of 1.39 and a beta of 1.20. Molina Healthcare has a 52-week low of $56.67 and a 52-week high of $93.98.
Molina Healthcare (NYSE:MOH) last issued its earnings results on Monday, April 30th. The company reported $1.71 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.81 by $0.90. The business had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.74 billion. Molina Healthcare had a positive return on equity of 20.08% and a negative net margin of 2.46%. The company’s quarterly revenue was down 5.3% on a year-over-year basis. During the same period in the previous year, the firm posted $0.63 EPS. research analysts expect that Molina Healthcare will post 4.63 EPS for the current fiscal year.
A number of analysts have recently commented on the company. Morgan Stanley boosted their price objective on Molina Healthcare from $91.00 to $100.00 and gave the stock an “overweight” rating in a research note on Tuesday, May 1st. ValuEngine raised Molina Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, March 2nd. BMO Capital Markets dropped their price objective on Molina Healthcare from $98.00 to $85.00 and set a “market perform” rating on the stock in a research note on Wednesday, February 14th. Jefferies Group reissued a “hold” rating and issued a $80.00 price objective on shares of Molina Healthcare in a research note on Wednesday, February 14th. Finally, Zacks Investment Research raised Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $96.00 price objective on the stock in a research note on Tuesday, April 17th. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. Molina Healthcare currently has a consensus rating of “Hold” and a consensus target price of $80.92.
Molina Healthcare Profile
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare (NYSE:MOH).
No comments:
Post a Comment